COVID-19 Research and NICHD

If you are looking for information about COVID-19 symptoms, diagnoses, and treatments, visit

Visit the Centers for Disease Control and Prevention’s page on COVID-19 Vaccination Considerations for People Who Are Pregnant for information to assist pregnant people with their decision to receive the COVID-19 vaccine.

Terms to know:

  • COVID-19: coronavirus disease
  • SARS-CoV-2: severe acute respiratory syndrome coronavirus 2; the virus that causes COVID-19
  • MIS-C: multisystem inflammatory syndrome in children; a condition that may result from previous exposure to SARS-CoV-2

Since the beginning of the COVID-19 pandemic, NICHD has worked to understand the effects of the virus among populations central to the NICHD mission, including pregnant and postpartum women, children and adolescents, people with intellectual and developmental disabilities, and people with physical disabilities or mobility impairments.

The institute has generated research proposals and projects; collaborated with other NIH institutes, centers, and offices (ICOs) and federal agencies; and initiated studies to help build a research base on SARS-CoV-2 virus.

NICHD also continues to advocate for the inclusion of its key populations in major trans-NIH programs, including the Rapid Acceleration of Diagnostics (RADx) initiative, the Accelerating COVID-19 Therapeutic Interventions and Vaccines (ACTIV) Initiative, and other projects.

For more on NICHD’s response to COVID-19, read the Director’s Corner blog post, Responding to COVID-19.

This information highlights some of NICHD’s COVID-19 research activities.

top of pageBACK TO TOP